The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move highlighting deepening liquidity challenges in the medical imaging sector, Nano-X Imaging (NNOX) withdrew its FY26 guidance and issued a going concern warning, according to reports. The announcement follows the company's struggle to generate significant revenue from its core Nanox.ARC device while continuing to burn cash.
The company had earlier reported Q1 revenue of $4.3M, up 53% year-on-year, but most of that came from teleradiology and AI/Health IT segments rather than hardware. Analysts flag that the business model remains under pressure for sustainable profitability.
Sign in to access this content
Sign InAs of the June 25, 2026 close, NNOX traded at $0.88, with a recent range of $0.73 to $1.18. No near-term catalysts appear on the economic calendar, leaving the stock exposed to further downside risk given the going concern uncertainty.